Product: Hepasil, sold in bulk of 500,000 capsules.
Reason for recall: Pursuant to a consent decree that prohibits the company and its owners for marketing dietary supplements until they, among other things, recall and destroy the dietary supplements that have been manufatured or distributed since April 2, 2014, hire a cGMP expert and receive written permission from FDA to resume operations.
Recall initiated: 20151005
Status: Terminated
Classification: Class II
Recall type: FDA Mandated